Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies
Charlotte E. J. Downes, Barbara J. McClure, Daniel P. McDougal, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 20

Showing 20 citing articles:

Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer
Junjun Jia, Xuelian Zhou, Qingfei Chu
Molecular and Cellular Biochemistry (2024) Vol. 480, Iss. 1, pp. 1-17
Closed Access | Times Cited: 10
Direct STAT3 and STAT5 Inhibition Overcomes Treatment Resistance in a Murine Derived In Vitro Model of Acute Lymphoblastic Leukaemia driven by ETV6::JAK2
Jane Frances Thompson, Randall Grose, David T Yeung, et al.
Acta Haematologica (2025), pp. 1-8
Open Access
Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry
Vikas Bhuria, Tobias Franz, Conny K. Baldauf, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Endometrial polyps with bizarre stromal cells: a Benign or a low-grade lesion?
Musen Wang, Fei Gao, Hongkai Zhang, et al.
BMC Women s Health (2025) Vol. 25, Iss. 1
Open Access
Integrative Insights into Philadelphia-like B-Cell Acute Lymphoblastic Leukemia: A Genetic and Molecular Landscape
S E Chuang, Apple H. Chu, Rodrigo Hurtado, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 385-385
Open Access
Effective Utilization of a Customized Targeted Hybrid Capture RNA Sequencing in the Routine Molecular Categorization of Adolescent and Adult B-Lineage Acute Lymphoblastic Leukemia: A Real-World Experience
Sreejesh Sreedharanunni, Venus Thakur, Anand Balakrishnan, et al.
Molecular Diagnosis & Therapy (2025)
Closed Access
Transcriptome analysis of primary adult B‐cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis
Mirjam Podgorica, Elsa Drivet, Jonas Krag Viken, et al.
European Journal Of Haematology (2024) Vol. 112, Iss. 5, pp. 731-742
Open Access | Times Cited: 2
SOHO State of the Art Updates and Next Questions | Approach to BCR::ABL1-Like Acute Lymphoblastic Leukemia
Ilaria Iacobucci, Cristina Papayannidis
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access | Times Cited: 2
PAX5 fusion genes in acute lymphoblastic leukemia: A literature review
Fatma Mohamed Fouad, Jehane I. Eid
Medicine (2023) Vol. 102, Iss. 20, pp. e33836-e33836
Open Access | Times Cited: 6
New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation
Matthew L. Arwood, Yao Liu, Shannon Harkins, et al.
Cell chemical biology (2023) Vol. 30, Iss. 6, pp. 618-631.e12
Open Access | Times Cited: 4
Trending Drugs Combination to Target Leukemia associated Proteins/Genes: using Graph Neural Networks under the RAIN Protocol
Mahnaz Boush, Ali Akbar Kiaei, Hossein Mahboubi
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Non-coding RNAs: Emerging biomarkers and therapeutic targets in ulcerative colitis
Imran Kazmi, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155037-155037
Closed Access | Times Cited: 4
The Role of the JAK–STAT Pathway in Childhood B-Cell Acute Lymphoblastic Leukemia
Karolina Ziętara, Kinga Wróblewska, Monika Zajączkowska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6844-6844
Open Access | Times Cited: 1
TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia
Hossam R. Alkashgari, Caleb Ruiz-Jiménez, Cornelia Stoian, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 474-474
Open Access | Times Cited: 6
Case Report: Whole genome sequencing identifies CCDC88C as a novel JAK2 fusion partner in pediatric T-cell acute lymphoblastic leukemia
Jelena Krstić, Fatemah Rezayee, Leonie Saft, et al.
Frontiers in Pediatrics (2023) Vol. 10
Open Access | Times Cited: 3
Clinical features and prognosis of pediatric acute lymphocytic leukemia with JAK-STAT pathway genetic abnormalities: a case series
Mengze Hu, Rong Liu, Juanjuan Li, et al.
Annals of Hematology (2023) Vol. 102, Iss. 9, pp. 2445-2457
Open Access | Times Cited: 3
Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement—A 10-case study and literature review
Ling Zhang, Bijal Shah, Yumeng Zhang, et al.
Human Pathology (2023) Vol. 136, pp. 1-15
Closed Access | Times Cited: 2
Unraveling the Genetic Heterogeneity of Acute Lymphoblastic Leukemia Based on NGS Applications
V. Maldonado, J. Acosta, Irene Marcos, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3965-3965
Open Access
Clonal heamatopoiesis and associated cardiovascular diseases
Kazuko Tajiri, Yasuhito Suehara, Toshio Suzuki, et al.
Japanese Journal of Clinical Oncology (2023) Vol. 53, Iss. 3, pp. 187-194
Open Access | Times Cited: 1
Ruxolitinib inhibits the proliferation and induces the apoptosis of MLL-r ALL cells through inactivating JAK/STAT signaling pathway
Xiong‐yu Liao, Dun‐hua Zhou, Jian‐Pei Fang, et al.
Translational Pediatrics (2023) Vol. 12, Iss. 6, pp. 1088-1097
Open Access | Times Cited: 1
Page 1

Scroll to top